Melanoma
non-CME
HUB
Tawnya Bowles, MD (she/her/hers)
Medical Director, Surgical Oncology
Intermountain Health
Murray, Utah, United States
Disclosure information not submitted.
The management of very high risk cutaneous squamous cell carcinoma continues to evolve and we will discuss the role of sentinel node biopsy in this patient population. The second half of the session will discuss whether definitive radiation treatment should supplant standard of care surgical resection followed by adjuvant radiation treatment for Merkel cell carcinoma.
HUB Presenter: Nasreen A. Vohra, MD, FACS – Brody School of Medicine
HUB Presenter: John Miura, MD – Hospital of the University of Pennsylvania